Impact of resection on overall survival of recurrent Glioblastoma in elderly it patients

被引:18
作者
Hager, Jasmin [1 ]
Herrmann, Eva [2 ]
Kammerer, Sarah [3 ]
Dinc, Nazife [1 ]
Won, Sae-Yeon [1 ]
Senft, Christian [1 ]
Seifert, Volker [1 ]
Marquardt, Gerhard [1 ]
Quick-Weller, Johanna [1 ]
机构
[1] Goethe Univ Frankfurt, Clin Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Inst Biostat & Math Modelling, Frankfurt, Germany
[3] Goethe Univ Frankfurt, Inst Neuroradiol, Frankfurt, Germany
关键词
Glioblastoma; Recurrent glioblastoma; Resection; Reresection; Tumor recurrence; Survival; Elderly patients; RADIOTHERAPY; TEMOZOLOMIDE; SURGERY; CHEMOTHERAPY; MULTIFORME; THERAPY; EXTENT;
D O I
10.1016/j.clineuro.2018.08.033
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Glioblastoma multiforme (GBM) mostly affects elderly patients. Adequate therapy especially in case of tumor recurrence is still under discussion, since most studies focus on patients under 65 years. We evaluated the impact of second surgery in regard to progression free survival (PFS) and overall survival (OAS) in elderly patients. Patients and methods: 59 patients with recurrent glioblastoma multiforme were retrospectively evaluated. Patients were divided into three subgroups: stereotactic biopsy (STX), resection and second resection. Second and third group were pooled as "surgery' after first diagnosis. The median age for all groups was 71 years.The primary endpoint was overall survival. Statistical analysis was calculated using Kaplan-Meier analysis and SPSS. Results: OAS was significantly longer for patients who had undergone surgery compared to the STX group. For patients who underwent reresection OAS was not significantly longer. Age (over 71) had no significant effect on OAS. PFS was significantly increased in patients who underwent surgery compared to those who underwent STX. PFS was not significantly longer in patients who underwent second resection. Furthermore PFS was not significantly different between patients under 71 and over. Conclusion: OAS and PFS were significant increased for patients who underwent surgery compared to only STX. Patients showed prolonged survival of almost 4 months after they underwent reresection (p > 0.05). Therapy of elderly patients with GBM remains an individual decision with priority on quality of life. Clinical status, comorbidities and family background) should be taken into account.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 27 条
[1]   Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article [J].
Bloch, Orin ;
Han, Seunggu J. ;
Cha, Soonmee ;
Sun, Matthew Z. ;
Aghi, Manish K. ;
McDermott, Michael W. ;
Berger, Mitchel S. ;
Parsa, Andrew T. .
JOURNAL OF NEUROSURGERY, 2012, 117 (06) :1032-1038
[2]   A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999 [J].
Chakrabarti, I ;
Cockburn, M ;
Cozen, W ;
Wang, YP ;
Preston-Martin, S .
CANCER, 2005, 104 (12) :2798-2806
[3]  
Cloney Michael, 2016, World Neurosurg, V89, P362, DOI 10.1016/j.wneu.2015.12.096
[4]   Risk of ischemia in glioma surgery: comparison of first and repeat procedures [J].
Duetzmann, Stephan ;
Gessler, Florian ;
Bink, Andrea ;
Quick, Johanna ;
Franz, Kea ;
Seifert, Volker ;
Senft, Christian .
JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (03) :599-607
[5]  
Easaw JC, 2011, CURR ONCOL, V18, pE126
[6]   Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas [J].
Fogh, Shannon E. ;
Andrews, David W. ;
Glass, Jon ;
Curran, Walter ;
Glass, Charles ;
Champ, Colin ;
Evans, James J. ;
Hyslop, Terry ;
Pequignot, Edward ;
Downes, Beverly ;
Comber, Eileen ;
Maltenfort, Mitchell ;
Dicker, Adam P. ;
Werner-Wasik, Maria .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18) :3048-3053
[7]   Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma [J].
Friedman, Henry S. ;
Prados, Michael D. ;
Wen, Patrick Y. ;
Mikkelsen, Tom ;
Schiff, David ;
Abrey, Lauren E. ;
Yung, W. K. Alfred ;
Paleologos, Nina ;
Nicholas, Martin K. ;
Jensen, Randy ;
Vredenburgh, James ;
Huang, Jane ;
Zheng, Maoxia ;
Cloughesy, Timothy .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4733-4740
[8]   Age alone is not a predictor for survival in glioblastoma [J].
Gately, Lucy ;
Collins, Anna ;
Murphy, Michael ;
Dowling, Anthony .
JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (03) :479-485
[9]   Glioblastoma in the elderly - How do we choose who to treat? [J].
Lorimer, Cressida F. ;
Saran, Frank ;
Chalmers, Anthony J. ;
Brock, Juliet .
JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (06) :453-456
[10]   Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial [J].
Malmstrom, Annika ;
Gronberg, Bjorn Henning ;
Marosi, Christine ;
Stupp, Roger ;
Frappaz, Didier ;
Schultz, Henrik ;
Abacioglu, Ufuk ;
Tavelin, Bjorn ;
Lhermitte, Benoit ;
Hegi, Monika E. ;
Rosell, Johan ;
Henriksson, Roger .
LANCET ONCOLOGY, 2012, 13 (09) :916-926